Role of IGF-1/IGFBP3 in non-small cell lung cancer sensitivity to therapy.

被引:0
|
作者
Ibanez de Caceres, Inmaculada
Holgado, Esther
Pernia, Olga
De Castro, Javier
Hitt, Ricardo
Conde, Esther
Lopez-Rios, Fernando
Cortes Semperes, Maria
Perona, Rosario
Belda-Iniesta, Cristobal
机构
[1] IdiPAZ, INGENM, Madrid, Spain
[2] Ctr Integral Oncol Clara Campal, Madrid, Spain
[3] Biomed Res Inst, Madrid, Spain
[4] La Paz Univ Hosp, Dept Med Oncol, Madrid, Spain
[5] CIOCC, Lab Dianas Terapeut, Madrid, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e19123
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Expressions of IGF-1R and IGFBP3 in Advanced Non-small Cell Lung Cancer (NSCLC)
    Kim, Y. H.
    Sumiyoshi, S.
    Hashimoto, S.
    Masago, K.
    Togashi, Y.
    Sakamori, Y.
    Okuda, C.
    Mio, T.
    Mishima, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S636 - S636
  • [2] IGF-1, IGFBP-3 AND VEGF IN SMALL CELL LUNG CANCER PATIENTS
    Wojcik, Ewa
    Sas-Korczynska, Beata
    Kulpa, Jan Kanty
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1057 - S1058
  • [3] The role of IGF-1 and IGFBP3 in acute liver failure.
    Clark, S
    Medici, E
    Jones, J
    Miell, J
    Wendon, JA
    HEPATOLOGY, 1998, 28 (04) : 608A - 608A
  • [4] Expression and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues from patients with non-small cell lung cancer
    Wang, Zhigang
    Wang, Zheng
    Liang, Zhu
    Liu, Jikuan
    Shi, Weicheng
    Bai, Peiru
    Lin, Xialu
    Magaye, Ruth
    Zhao, Jinshun
    ONCOTARGETS AND THERAPY, 2013, 6 : 1437 - 1444
  • [5] Polymorphisms in the IGF-1 and IGFBP3 promoter and the risk of breast cancer
    Wagner, K
    Hemminki, K
    Israelsson, E
    Grzybowska, E
    Söderberg, M
    Pamula, J
    Pekala, W
    Zientek, H
    Mielzynska, D
    Siwinska, E
    Försti, A
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 92 (02) : 133 - 140
  • [6] Polymorphisms in the IGF-1 and IGFBP3 promoter and the risk of breast cancer
    Kerstin Wagner
    Kari Hemminki
    Elisabeth Israelsson
    Ewa Grzybowska
    Magnus Söderberg
    Jolanta Pamula
    Wioletta Pekala
    Helena Zientek
    Danuta Mielzynska
    Ewa Siwinska
    Asta Försti
    Breast Cancer Research and Treatment, 2005, 92 : 133 - 140
  • [7] IGF-1 and IGFBP3 levels in normal and diabetic pregnancy
    Russell, Noreen
    Brazil, Derek
    Coffey, Mary
    Foley, Michael
    McAuliffe, Fionnuala
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (06) : S137 - S137
  • [8] Serum IGF-1 and IGFBP3 in Inflammatory Bowel Disease.
    Tsianos, EV
    Katsanos, KH
    Christodoulou, DK
    Kitsanou, M
    Holevas, V
    Gartzonika, K
    Eleftheriou, A
    Challa, A
    Tsatsoulis, A
    GASTROENTEROLOGY, 2000, 118 (04) : A1373 - A1373
  • [9] Prognostic significance of IGF-1 signaling pathway in patients with advanced non-small cell lung cancer
    Kotsantis, I.
    Economopoulou, P.
    Psyrri, A.
    Maratou, E.
    Pectasides, D.
    Gogas, H.
    Kentepozidis, N.
    Mountzios, G.
    Dimitriadis, G.
    Giannouli, S.
    ANNALS OF ONCOLOGY, 2019, 30 : 10 - 10
  • [10] Expression of IGF-1, IGFBP3, and IGF-1Ralpha in human wisdom teeth.
    Ahrens, S.
    Mustafa, T.
    Boehm, B.
    Reichert, S.
    Eckert, A. W.
    Schubert, J.
    Hoang-Vu, C.
    JOURNAL OF DENTAL RESEARCH, 2003, 82 : B252 - B252